NCT03311373 - A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 17, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Regimen A

2 inhalations BGF MDI; no spacer device; no oral charcoal - reference formulation/total systemic exposure

DRUG

Regimen B

2 inhalations BGF MDI; AeroChamber Plus Flow-Vu spacer device; no oral charcoal - test formulation/total systemic exposure

DRUG

Regimen C

2 inhalations BGF MDI; no spacer device; with oral charcoal - reference formulation/lung exposure

DRUG

Regimen D

2 inhalations BGF MDI; AeroChamber Plus Flow-Vu spacer device; with oral charcoal - test formulation/lung exposure

Trial Locations (1)

Pearl Investigative Site, Baltimore